|
|||||
A company using genomic databases and artificial intelligence to discover new therapies for neurodegenerative diseases is raising $32 million in its first venture funding round. . . . → Read More: A.I. Drug Discovery Company Gains $32M in Early Funds 
A life science and health care investment company in the U.K. today revealed its 12th venture capital fund for start-up and current enterprises in the U.S. and Europe. . . . → Read More: New $315 Million Life Sciences Venture Fund Unveiled 
A biotechnology lab devised techniques for genetically engineered bacteria to produce synthetic proteins that can last longer and are more stable than current protein production methods. . . . → Read More: Bacterial Genome Recoded to Produce Stable Protein Drugs  One comment - (Comments are closed)  New products  biomedical, biotechnology, chemistry, entrepreneurs, equity, investment, life sciences, pharmaceuticals, physical sciences, university, venture capital 
In a report this week, our friends at CB Insights note that the investment community is waiting for graphene to reach a critical commercial mass, but their patience may be running out. . . . → Read More: Infographic – Graphene Investment in Decline One comment - (Comments are closed) Finance engineering, entrepreneurs, equity, investment, materials science, nanotechnology, physical sciences, U.K., venture capital 
A company is getting underway to develop therapies that extend genome editing to repair genetic disruptions, not just remove them from DNA. . . . → Read More: Genetic Repair Company Starts-Up, Gains $87 Million 2 comments - (Comments are closed) Finance, Intellectual property biomedical, biotechnology, entrepreneurs, equity, genomics, investment, licensing, life sciences, pharmaceuticals, university, venture capital 
Biotechnology company Genentech is licensing a process from a start-up enterprise that discovers small molecule drugs from naturally occurring microbes found in soil. . . . → Read More: Genentech Gains Microbe Drug Discovery Tech in $1B Deal Comments are closed Intellectual property biomedical, biotechnology, chemistry, entrepreneurs, equity, genomics, investment, licensing, life sciences, pharmaceuticals, physical sciences, university, venture capital 
One indicator of Google’s expanding involvement in health care is its venture investments in digital health and health technology start-ups, which is this weekend’s infographic. . . . → Read More: Infographic – Google Health Care Investments Take Off Comments are closed Finance biomedical, engineering, investment, life sciences, software, venture capital
A start-up enterprise is discovering therapies to address a variety of disorders that result from faulty cell degradation processes known as autophagy, which when functioning normally contribute to cell health. . . . → Read More: New Cell Therapy Company Raises $58.5M in Early Funds Comments are closed Finance biomedical, biotechnology, entrepreneurs, equity, investment, life sciences, pharmaceuticals, university, venture capital A new enterprise is formed to develop treatments for cancer using donated T-cells from the immune system, rather than the patient’s own T-cells, engineered to attack cancer cells. . . . → Read More: New Company Acquires Off-the-Shelf T-Cell Cancer Therapies One comment - (Comments are closed) Finance, Intellectual property, Joint ventures/collaborations biomedical, biotechnology, cancer, entrepreneurs, equity, genomics, investment, licensing, life sciences, patent, pharmaceuticals, venture capital A device sending electrical pulses through a main nerve pathway is starting a clinical trial to test the device in people with rheumatoid arthritis, an autoimmune disease affecting joints and surrounding tissue. . . . → Read More: Nerve Stimulation Device Being Tested for Arthritis Comments are closed New products biomedical, clinical trials, engineering, entrepreneurs, life sciences, medical device, physical sciences, venture capital |
One Blood Test Fits All Diseases A Thinking Person’s Artificial Intelligence Do You Want Your Bacon CRISPR? Health Care, Precisely One Person at a Time Let Guinea Pigs be Guinea Pigs Look Out Pharma. The Tech Industry is After You |
||||
|
Copyright © 2018 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
